Source: Health Products Regulatory Authority (ZA) Revision Year: 2021 Publisher: Pfizer Laboratories (Pty) Ltd, 85 Bute Lane, Sandton 2196, South Africa Tel: +27 (0)11) 320 6000 / 0860 734 937 (Toll-free South Africa)
DAUNOBLASTIN Injection.
| Pharmaceutical Form |
|---|
|
Powder for solution for injection. Orange-red freeze-dried cake. |
Each vial contains 20 mg daunorubicin hydrochloride.
Contains sugar alcohol (mannitol).
Excipients with known effect: Each vial contains 100 mg mannitol.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Daunorubicin |
Daunorubicin is an anthracycline glycoside antibiotic and is a potent antileukaemic agent. It also has immunosuppressant effects. Daunorubicin may involve binding to DNA by intercalation between base pairs and inhibition of DNA and RNA synthesis by template disordering and steric obstruction. |
| List of Excipients |
|---|
|
Mannitol |
Colourless glass vial containing 20 mg daunorubicin hydrochloride.
Pfizer Laboratories (Pty) Ltd, 85 Bute Lane, Sandton 2196, South Africa
Tel: +27 (0)11) 320 6000 / 0860 734 937 (Toll-free South Africa)
V/26/239
05 December 1988
| Drug | Countries | |
|---|---|---|
| DAUNOBLASTIN | Estonia, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
